Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Asian Pacific Journal of Cancer Prevention : APJCP|October 27, 2017
Pegfilgrastim Versus Filgrastim for Primary Prophylaxis of Febrile Neutropenia in Patients with non-Hodgkin’s Lymphoma: A Cost-Effectiveness StudyRamin Ravangard, Najme Bordbar, Khosro Keshavarz, et al.
Cost Effectiveness and Resource Allocation : C/E|July 23, 2023
Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in IranZahra Goudarzi, Fattaneh Danayi, Khosro Keshavarz, et al.
Biomed Research International|December 8, 2021
Cost-Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and EtanerceptAhmad Gholami, Jassem Azizpoor, Elham Aflaki, et al.
BMC Infectious Diseases|April 18, 2025
The impact of COVID-19: consequences of a 3-Year struggle in IranHabib Omranikhoo, Hedayat Salari, Khosro Keshavarz, et al.
Health Economics Review|January 4, 2022
Economic burden of multiple sclerosis: a cross-sectional study in IranMehdi Rezaee, Khosro Keshavarz, Sadegh Izadi, et al.
Journal of Medical Economics|December 19, 2018
Fingolimod versus natalizumab in patients with relapsing remitting multiple sclerosis: a cost-effectiveness and cost-utility study in IranMehdi Rezaee, Sadegh Izadi, Khosro Keshavarz, et al.
Archives of Iranian Medicine|February 16, 2020
Can Health be Related to Interpersonal Violence in Middle Eastern Countries?Mohsen Bayati, Farhad Lotfi, Khosro Keshavarz, et al.
Iranian Journal of Medical Sciences|March 16, 2022
Cost-Effectiveness Analysis of Intraoperative Frozen Section in Women with Breast Cancer: Evidence from South of IranNavid Omidifar, Elham Chogani, Vahid Zangouri, et al.
Hematology (Amsterdam, Netherlands)|February 17, 2021
A cost-effectiveness analysis of the prophylaxis versus on-demand regimens in severe hemophilia A patients under 12 years old in southern IranZohreh Zahedi, Mehran Karimi, Khosro Keshavarz, et al.
Hematology (Amsterdam, Netherlands)|November 22, 2017
Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness studyRamin Ravangard, Zahra Mirzaei, Khosro Keshavarz, et al.
Pageof 7